Breaking News Instant updates and real-time market news.

SUM

Summit Materials

$19.04

0.14 (0.74%)

, CX

Cemex

$7.12

0.045 (0.64%)

09:18
09/15/18
09/15
09:18
09/15/18
09:18

Cement and rock stocks should bounce back, Barron's says

Despite the robust economy, companies that mine and mix the base materials for new roads and buildings have fallen this year, with several dropping more than 20%, Avi Salzman of Barron's writes in a story titled "Expect Cement and Rock Stocks to Bounce." The stock slump is not likely to last, argues Salzman. Absent a recession, companies in this industry tend to have strong pricing power and should benefit as cities and states "shore up crumbling infrastructure," Salzman contends. The writer says Summit Materials (SUM) could be worth 25% more than today if it gets back to its average forward price-to-earnings multiple of about 19 times. Other names in the space include Cemex (CX), Eagle Materials (EXP), Martin Marietta Materials (MLM), US Concrete (USCR) and Vulcan Materials (VMC). "The stocks are going down on weather issues; it's not like they're losing that business, it's delayed," Craig Hodges, chief executive of Hodges Capital Management, told Barron's. Reference Link

SUM

Summit Materials

$19.04

0.14 (0.74%)

CX

Cemex

$7.12

0.045 (0.64%)

EXP

Eagle Materials

$87.53

-0.4 (-0.45%)

MLM

Martin Marietta

$194.06

0.91 (0.47%)

USCR

U.S. Concrete

$50.20

1.7 (3.51%)

VMC

Vulcan Materials

$111.19

1.53 (1.40%)

  • 26

    Sep

  • 06

    Nov

SUM Summit Materials
$19.04

0.14 (0.74%)

08/02/18
RBCM
08/02/18
NO CHANGE
Target $27
RBCM
Outperform
Summit Materials price target lowered to $27 from $35 at RBC Capital
RBC Capital analyst Mike Dahl lowered his price target on Summit Materials to $27 after its disappointing Q2 results and a cut in FY18 adjusted EBITDA guidance. The analyst keeps his Outperform rating on the stock however, citing attractive valuation following a 16% post-earnings slide as well as "multiple levers" for the company to accelerate its growth.
06/27/18
RBCM
06/27/18
INITIATION
RBCM
Outperform
Summit Materials assumed with an Outperform at RBC Capital
RBC Capital analyst Michael Dahl assumed Summit Materials with a Outperform rating and a $35 price target.
09/11/18
DBAB
09/11/18
NO CHANGE
Target $30
DBAB
Buy
Summit Materials investor deck points to lowered outlook, says Deutsche Bank
Summit Materials didn't explicitly lower fiscal 2018 guidance with its new investor slide deck, but everything the company disclosed points in that direction, Deutsche Bank analyst Nishu Sood tells investors in a research note. The new deck, released just three weeks after the last one, describes poor weather across one-third of its operations, continued competitive pressures in the cement business and even higher asking multiples on transactions, Sood points out. The analyst lowered his fiscal 2018 EBITDA estimate to $465M from $470M and sees added risk to second half of 2018 numbers. However, Sood keeps a Buy rating on Summit Materials with a $30 price target, citing the stock's "significant valuation discount to peers."
06/12/18
JEFF
06/12/18
NO CHANGE
Target $37
JEFF
Buy
Summit Materials trades at 40% discount to peers, says Jefferies
After meeting with Summit Materials management, Jefferies analyst Philip Ng says he's encouraged trends have picked up and the macro backdrop remains favorable. While the company is seeing increased competition in cement and its guidance is back end loaded, these dynamics are reflected in the shares following the recent weakness, Ng tells investors in a research note. He believes believe Summit offers good value trading at a 40% discount to its peers. The analyst keeps a Buy rating on the name with a $37 price target.
CX Cemex
$7.12

0.045 (0.64%)

08/16/18
HSBC
08/16/18
DOWNGRADE
HSBC
Hold
Cemex downgraded to Hold from Buy at HSBC
08/16/18
08/16/18
DOWNGRADE
Target $9

Hold
Cemex downgraded to Hold at HSBC
As previously reported, HSBC downgraded Cemex to Hold from Buy and lowered its price target to $7.70 from $9. Analyst Eduardo Altamirano said Cemex's deleveraging remains intact, but the pace at which debt is converted to equity is slowing down due to weaker than expected pricing and volumes in most regions, combined with higher input costs. Altamirano now sees near-term free cash flow equal for both equity and debt holders, limiting upside for equity holders.
08/16/18
08/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Hold from Buy at Jefferies with analyst Ian Hilliker citing valuation following the stock's outperformance since he upgraded it in March. 2. Cemex (CX) downgraded to Hold from Buy at HSBC with analyst Eduardo Altamirano saying Cemex's deleveraging remains intact, but the pace at which debt is converted to equity is slowing down due to weaker than expected pricing and volumes in most regions, combined with higher input costs. 3. Cenovus Energy (CVE) downgraded to Hold from Buy at Canaccord with analyst Dennis Fong saying cash flow valuation is in line versus the large-cap group, which he thinks is appropriate given the company's above-average heavy oil exposure, moderated production growth profile, and higher leverage. 4. Nanometrics (NANO) downgraded to Neutral from Buy at DA Davidson with analyst Thomas Diffely saying that after outperforming its peer group over the past few years, the stock now trades at a 40% premium to its peers. 5. Coty (COTY) downgraded to Underperform from Buy at BofA/Merrill with analyst Olivia Tong citing inconsistent execution and increasing disruption across the mass beauty segment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/18
SBSH
09/04/18
NO CHANGE
Target $9.5
SBSH
Buy
Cemex worth $15 per share on asset-based valuation, says Citi
Citi analyst Dan McGoey, while continuing to favor a cash flow valuation analysis, says an asset-based valuation points to shares of Cemex being worth $15. The analyst estimates the gross value of Cemex's cement operations at $26B, the concrete division at $4B, Aggregates division at $1.7B, land and marine distribution terminals at $2B and its equity investments at $700M. The stock remains attractively valued under traditional multiples as well, McGoey tells investors in a research note. He keeps a Buy rating on Cemex with a price target of $9.50.
EXP Eagle Materials
$87.53

-0.4 (-0.45%)

03/23/18
03/23/18
UPGRADE
Target $133

Buy
Eagle Materials upgraded to Buy on wallboard pricing improvement at Longbow
As previously reported, Longbow upgraded Eagle Materials to Buy from Neutral with a $133 price target. Analyst Garik Shmois's recent wallboard survey indicates pricing is tracking 200bp ahead of his prior expectations. In addition, Shmois said cement fundamentals are improving, energy markets provide upside, and balance sheet flexibility are additional catalysts.
04/17/18
JEFF
04/17/18
INITIATION
Target $121
JEFF
Buy
Eagle Materials initiated with a Buy at Jefferies
Jefferies analyst Philip Ng started Eagle Materials with a Buy rating and $121 price target. The analyst finds the stock "compelling" given Eagle's "industry high" margins and its optionality from capital deployment.
06/13/18
06/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sprint (S) upgraded to Outperform from Market Perform at Raymond James. 2. ASML (ASML) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mitch Steves citing his positive view of the company's EUV lithography system deployment in 2019, adding that its operating margins will also likely be safe despite the higher related spending. 3. Eagle Materials (EXP) upgraded to Buy from Neutral at Northcoast. 4. Signature Bank (SBNY) upgraded to Overweight from Neutral at Piper Jaffray with analyst Matthew Breese saying despite the stock's 8% decline year-to-date, he views the company's fundamentals as improved based on management commentary and a recent uptick in New York City multi-family transaction data. 5. Telefonica Brasil (VIV) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Cesar Medina saying he now prefers the stock over Tim Participacoes (TSU). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/18
NRCS
06/13/18
UPGRADE
NRCS
Buy
Eagle Materials upgraded to Buy from Neutral at Northcoast
MLM Martin Marietta
$194.06

0.91 (0.47%)

06/07/18
JEFF
06/07/18
NO CHANGE
JEFF
Martin Marietta added to Franchise Picks list at Jefferies
Jefferies analyst Philip Ng added shares of Martin Marietta Materials to his firm's Franchise Picks list with a Buy rating and $256 price target. The Building Products group has seen "massive" multiple compression with investors fearful we're near a cyclical peak in housing due to rising rates and inflation, Ng tells investors in a research note. He believes these concerns are overblown and calls Martin Marietta, Owens Corning (OC) and Masco (MAS) his top picks.
05/15/18
SBSH
05/15/18
NO CHANGE
Target $262
SBSH
Buy
Martin Marietta price target raised to $262 from $255 at Citi
Citi analyst Scott Schrier raised his price target for Martin Marietta Materials to $262 after adding the impact of the Bluegrass Materials acquisition to his forecast. The analyst keeps a Buy rating on the shares.
05/03/18
RHCO
05/03/18
NO CHANGE
Target $226
RHCO
Buy
Martin Marietta price target lowered to $226 from $245 at SunTrust
SunTrust analyst Rohit Seth lowered his price target on Martin Marietta to $226, saying his Q1 EBITDA estimate was not "appropriately adjusted for seasonality" given the unfavorable weather. The analyst notes that valuation on the stock remains attractive, keeping his Buy rating on the stock.
05/02/18
05/02/18
UPGRADE
Target $229

Buy
Martin Marietta upgraded to Buy, demand intact, says BofA/Merrill
As previously reported, BofA/Merrill upgraded Martin Marietta to Buy from Neutral and trimmed its price target to $229 from $231. Analyst Timna Tanners said expectations have been reset, valuation is more appropriate, and sees "healthy" construction infrastructure spending benefits in 2019 and beyond.
USCR U.S. Concrete
$50.20

1.7 (3.51%)

05/18/18
DADA
05/18/18
NO CHANGE
Target $95
DADA
Buy
U.S. Concrete remains 'attractive investment opportunity,' says DA Davidson
DA Davidson analyst Brent Thielman says he continues to view U.S. Concrete as an "attractive investment opportunity" following yesterday's short report. While a bear thesis calling an end to the cycle may never completely abate as long as revenue continues to grow, stronger Q2 and Q3 results may help ease concerns regarding cycle momentum, Thielman tells investors in a research note partially titled "Still A Concrete Investment Here." He notes that U.S. Concrete, like essentially all other public heavy building materials suppliers, is a roll-up of local/regional operators serving distinct local markets. Further, he argues that U.S. Concrete's annual gross margins have been stable for three consecutive years, albeit with evident fluctuations quarter-to-quarter. The analyst keeps a Buy rating on the shares with a $95 price target.
05/17/18
STFL
05/17/18
NO CHANGE
STFL
Buy
U.S. Concrete short thesis 'isn't new,' says Stifel
Stifel analyst Stanley Elliott said Spruce Point's short thesis on U.S. Concrete "isn't new" and that much of it was similar to a prior short report from another firm released about two years ago. The analyst, who said the timing of this report is "interesting," still thinks the fundamental outlook for the business remains encouraging. Elliott maintains a Buy rating on U.S. Concrete.
03/02/18
DADA
03/02/18
NO CHANGE
Target $98
DADA
Buy
U.S. Concrete price target lowered to $98 from $105 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on U.S. Concrete to $98 after the company's "noisy" Q4 earnings that showed a miss in EPS and EBITDA driven by sales deferrals from adverse weather conditions. The analyst keeps his Buy rating on U.S. Concrete, saying its "concentrated ready-mix platform strategy and its advantages with suppliers and barriers to entry are underappreciated by the market".
08/07/18
RHCO
08/07/18
NO CHANGE
Target $70
RHCO
Buy
U.S. Concrete price target lowered to $70 from $86 at SunTrust
SunTrust analyst Rohit Seth lowered his price target on U.S. Concrete to $70 ahead of its earnings, saying the price/cost challenges expected by the market in Q2 are likely to lead to a reset of expectations for the rest of the year. While he keeps his Buy rating with risk-return profile of U.S. Concrete skewed to the upside, Seth points to the company's likely exposure in higher "truck driver labor costs/tightness, input materials, and diesel". Aside from the cost headwinds, the analyst adds that he will look for signs of higher pricing to generate more stable margins.
VMC Vulcan Materials
$111.19

1.53 (1.40%)

08/01/18
RBCM
08/01/18
UPGRADE
RBCM
Outperform
Vulcan Materials upgraded to Outperform from Sector Perform at RBC Capital
08/20/18
ARGS
08/20/18
NO CHANGE
Target $122
ARGS
Buy
Vulcan Materials price target lowered to $122 from $145 at Argus
Argus analyst David Coleman lowered his price target on Vulcan Materials to $122 after its Q2 earnings miss and relative underperformance over the past 3 months and year-to-date. The analyst also keeps his Buy rating on the stock over the longer term, saying that it "remains one of the best-positioned companies in the construction materials industry", with expectation of benefits comping from the "eventual increase in U.S. infrastructure spending and continued acquisitions." Coleman lowers his FY18 EPS view to $4.35 from $4.50, but expects Vulcan to benefit from growth in "infrastructure, residential, and commercial construction, as well as from recent acquisitions and its presence in high-growth geographic markets".
08/01/18
JEFF
08/01/18
UPGRADE
Target $137
JEFF
Buy
Vulcan Materials upgraded to Buy from Hold at Jefferies
Jefferies analyst Philip Ng upgraded Vulcan Materials to Buy with an unchanged price target of $137 following the company's Q2 results. The analyst sees a favorable setup with the company's pricing accelerating and comps easing on incrementals. He notes the stock is near two-year lows and trading at a discount to its historical average. Ng calls Vulcan one of his top picks.
08/01/18
RBCM
08/01/18
UPGRADE
Target $112
RBCM
Outperform
Vulcan Materials upgraded to Outperform at RBC Capital on valuation
As reported earlier, RBC Capital analyst Mike Dahl upgraded Vulcan Material to Outperform from Sector Perform and kept his $138 price target. The analyst cites an attractive entry point based on valuation, with the stock down 16% since mid-June and the recent mixed quarter marred by input cost inflation and a negative geographic mix contributing to the sell-off. The analyst notes however that the quarter also showed "solid volume growth and underlying price progression" while also pointing to strong demand trends, forecasting more pricing and margin upside in the coming quarters. At 14-times consensus next-twelve-month EBITDA multiple - the lowest valuation point over the past year - the analyst is more constructive on Vulcan Material.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.